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Abstract 
Background: WHO guidelines advocate breastfeeding for six months, and EAACI 
recommends exclusive breastfeeding for 4-6 months. However, evidence for 
breastfeeding to prevent asthma and allergic disease is conflicting. We examined 
whether following recommended breastfeeding guidelines alters the long-term risks of 
asthma, eczema, rhinitis, or atopy.  
 
Methods: The effect of non-exclusive (0, >0-6, >6 months), and exclusive breastfeeding 
(0, >0-4, >4 months) on repeated measures of asthma (10, 18 years), eczema, rhinitis, 
and atopy (1-or-2, 4, 10,18 years) risks were estimated in the IoW cohort (n=1456) using 
log-linear models with generalised estimating equations. The Food Allergy and 
Intolerance Research (FAIR) cohort (n=988), also from the IoW, was examined to 
replicate results. 
 
Results: Breastfeeding (any or exclusive) had no effect on asthma and allergic disease 
in the IoW cohort. In the FAIR cohort, any breastfeeding for >0-6 months protected 
against asthma at 10 years (RR=0.50, 95%CI=0.32-0.79, p=0.003) but not other 
outcomes, while exclusive breastfeeding for >4 months protected against repeated 
rhinitis (RR=0.36, 95%CI=0.18-0.71, p=0.003). Longer breastfeeding was protective 
against late-onset wheeze in the IoW cohort. 
 
Conclusion: The protective effects of non-exclusive and exclusive breastfeeding against 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
long-term allergic outcomes were inconsistent between these co-located cohorts, 
agreeing with previous observations of heterogeneous effects. Although breastfeeding 
should be recommended for other health benefits, following breastfeeding guidelines did 
not appear to afford consistent protection against long-term asthma, eczema, rhinitis or 
atopy. Further research is needed into the long-term effects of breastfeeding on allergic 
disease. 
Introduction 
The aetiology of allergy is multifactorial and comprises both genetic and environmental 
components. It is now recognised that the early life environment, including nutrition, has 
considerable effect on risk of several diseases including asthma and allergy. Early life 
nutrition can be provided by breastfeeding or formula feeds, followed by the introduction 
of complementary foods and weaning. Immunomodulatory breast milk components such 
as maternal antibodies are absent from formula, and also differ between mothers and 
between breast milk samples(3).  
 
Breastfeeding for at least six months is recommended, unless contraindicated, by World 
Health Organisation (WHO) guidelines (4). Exclusive breastfeeding is advised by the 
European Academy of Allergy and Clinical Immunology (EAACI) for at least four to six 
months (5), and EAACI guidelines state that “Breastfeeding has many benefits for 
mother and child and is therefore recommended for all infants. There is a small amount 
of evidence to support breastfeeding as a means of preventing the development of food 
allergy”. Although there is evidence that breastfeeding alters risk of several adult 
diseases, the potential benefits of breastfeeding for allergic disease are controversial. 
Additionally, the effect of breastfeeding according to the current clinical guidelines on 
long-term outcomes for allergic disease has not previously been investigated. 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Breastfeeding has been studied before in the Isle of Wight (IoW) birth cohort. Exclusive 
breastfeeding for the first three months of life is protective against early childhood atopic 
wheeze (6). Breastfeeding for over four months is associated with increased lung 
volume at age 10 (7). Increased lung function was also seen at age 18 but stratifying by 
height reduced this association (8). Additionally, prolonged breastfeeding mitigated the 
impact of maternal smoking during pregnancy and recurrent lower respiratory tract 
infection (RLRTI) on asthma risk (repeated measures up to age 10) (9). In the FAIR 
cohort, breastfeeding type (exclusive or non-exclusive) or duration has no effect on food 
allergy prevention in early childhood (10). However the long-term effect of breastfeeding 
on repeated asthma, eczema, rhinitis, and atopy up to age 18 is uncertain. 
 
In general, studies that report a protective effect of breastfeeding on allergic disease 
look at allergic outcomes in early childhood, and studies of the long-term effects are 
scarce, therefore the role of breastfeeding in allergic disease throughout adolescence 
needs further investigation (11). In particular, asthma diagnosis in early childhood is 
primarily based on wheeze so studies reporting an early protective effect of 
breastfeeding on ‘asthma’ may not identify those who continue to exhibit persistent 
asthma symptoms in adulthood. 
 
Crucially, categorisation of breastfeeding duration is widely variable, complicating inter-
study comparisons. Evidence for the effects of breastfeeding is inconsistent and often 
limited by the absence of a non-breastfed reference category (12, 13). This study aims 
to evaluate how appropriate breastfeeding guidelines are specifically for long-term 
asthma and allergic disease risk, in a longitudinal prospective birth cohort and validation 
cohort. We hypothesised that guideline breastfeeding would be protective against 
development of asthma and allergic disease. 
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Materials and Methods 
The Isle of Wight (IoW) cohort 
The IoW birth cohort (n=1456) was set up in 1989 to prospectively investigate the 
development of asthma and allergic disease. Mothers were approached at birth and 
following exclusion of subjects due to adoption, follow-up refusal, or perinatal deaths 
95% of children were enrolled. In line with ethical approval, written parental consent was 
obtained for all participants and follow-ups were conducted at 1, 2, 4, 10, and 18 years. 
The cohort has been described in detail elsewhere (14). All subjects with outcome data 
for at least one follow-up were included in analyses (n=1496, 1496, 1495, and 1289 for 
asthma, eczema, rhinitis, and atopy respectively). Since the 1-year and 2-year follow-
ups were completed in a relatively small time window, they were combined (reported as 
1-or-2 years). 
 
Variable definitions 
Breastfeeding duration data were obtained retrospectively at the 1-and-2 year follow-
ups. The minimum six months breastfeeding recommended by the WHO guidelines was 
used to categorise breastfeeding into ‘no breastfeeding’, ‘>0-6 months’, and ‘>6 months’ 
breastfeeding. 
 
Duration of exclusive breastfeeding duration was defined as the age at which formula 
feeding or solid foods were first introduced. According to EAACI guidelines (5), mothers 
should attempt to breastfeed exclusively from birth until four months unless 
contraindicated. Exclusive breastfeeding was therefore categorised into ‘no exclusive 
breastfeeding, ‘>0-4 months’, and ‘>4 months’. 
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Socioeconomic status was determined by combining parental occupation at birth, 
number of children in the index child’s bedroom, and family income as described 
previously (7). Maternal smoking during pregnancy was recorded at birth. RLRTI was 
defined as two or more episodes of parental report of chest infections, based on 
productive cough lasting for five or more days in the preceding 12 months. Antibiotic 
usage and wheezing were not prerequisites for the diagnosis of RLRTI. Information on 
RLRTI was collected at 1 and 2 years. Other variables included sex, birth order, season 
of birth, birthweight, gestational age, mode of delivery and parental history of allergy 
(ever).  
 
Asthma definition required both “history of physician-diagnosed asthma” and either 
“wheezing or whistling in the chest in the last 12 months” or “asthma treatment in the 
previous 12 months”. As asthma is difficult to diagnose with confidence in early 
childhood, we only used 10 and 18-year data for asthma. Eczema was defined as 
chronic or chronically relapsing itchy dermatitis lasting >6 weeks with characteristic 
morphology and distribution, following Hanifin and Rajka criteria (16). Rhinitis was 
defined as a problem with sneezing, or a runny or blocked nose without cold or flu in the 
last year (17). Atopy was determined by skin prick testing as described previously (17). 
 
The Food Allergy and Intolerance Research (FAIR) cohort was used for validation. The 
FAIR cohort (n=988) was established in 2001, and at present has follow-up to 10 years 
of age. The same definitions and methods were used in the FAIR cohort, except that 
maternal education was used as a proxy for maternal socioeconomic status, and no data 
were available for parental atopy or RLRTI. The FAIR cohort has been described in 
detail elsewhere (18). IoW results were validated in FAIR participants at ages 1, 2, 3, 
and 10 years. Loss to follow-up was minimal for both cohorts (Figure 1).  
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Statistical analyses 
The generalised additive models (GAM) implemented in our analyses utilised splines to 
semi-parametrically describe the association of asthma risk with breastfeeding duration 
in the IoW cohort. The PROC GAM procedure in SAS (2) was used to fit the model. This 
procedure also provided a test on the statistical significance with respect to a linear 
association of asthma risk with breastfeeding duration.  
 
χ2 tests were used to test the independence of factors associated with breastfeeding 
duration (maternal socioeconomic status, maternal smoking during pregnancy, sibling 
order, season of birth, sex, parental history of allergy, RLRTI, birthweight, gestational 
age, and mode of delivery (9, 19-24)), to identify potential confounding factors. Where 
available these factors were also tested in the FAIR cohort to assess whether any 
associations have changed over time on the Isle of Wight. Adjusted models therefore 
controlled for sex, birth order, maternal socioeconomic status, maternal smoking, season 
of birth, parental history of allergic outcome (asthma, eczema, rhinitis, or atopy) and in 
the case of asthma also RLRTI. Relative risks (RRs) of breastfeeding duration on 
repeated asthma, eczema, rhinitis, and atopy – both adjusted and unadjusted models – 
were calculated using log-linear models via generalised estimating equations. 
 
For asthma only long-term outcomes were investigated, following previous analyses of 
breastfeeding on early wheeze in the cohort (6). In the IoW cohort asthma at 10 and 18 
years and in the FAIR cohort asthma at age 10 were examined. Log linear models were 
used to calculate RRs for the 10-year data in the FAIR cohort. All statistical analyses 
used SPSS software (version 22.0.0, IBM). 
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Wheeze trajectories 
To analyse the effect of breastfeeding duration on subtypes of early wheeze, wheeze 
trajectories were constructed based on presence/absence of wheeze ages 1-or-2 and 4 
in the IoW cohort (25). These categories were never wheezed, early transient wheeze, 
late wheeze, and persistent wheeze (see Table S1). Log linear models were used to 
examine the effect of non-exclusive and exclusive breastfeeding on the trajectories, with 
‘never wheezed’ as the reference trajectory. Most adjusted models reached singularity 
for both non-exclusive and exclusive breastfeeding, so adjusted models only control for 
sex and RLRTI. 
 
Results 
Cohort characteristics 
Characteristics of the IoW and FAIR cohorts are presented in Table 1. In the IoW cohort 
there were approximately equal numbers of male and female participants. The majority 
of mothers initially tried to breastfeed, were non-smokers, and did not suffer from 
asthma, eczema, rhinitis, or atopy (Table 1), and 21% of mothers did not breastfeed at 
all. The prevalence of asthma, eczema, rhinitis, and atopy at 18 were 17.7%, 12.3%, 
35.8%, and 41.4% respectively. The FAIR cohort included more mothers who did not 
breastfeed (31.3%), and prevalence of asthma, eczema, rhinitis, and atopy at 10 were 
18.7%, 31.2%, 23.9%, 24.6% respectively. For asthma at age 10, GAM indicated a 
potential non-linear relationship (p=0.0613, Figure S1), which implies assuming linearity 
between breastfeeding duration and asthma risk is not appropriate. Furthermore, the 
non-linear pattern suggested a categorisation of breastfeeding around the 30 weeks time 
point, which agrees with the 6 months breastfeeding recommendation by the WHO.  
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Confounding factors 
Potential confounders were tested for association with breastfeeding duration (Tables S2 
and S3). In both cohorts, socioeconomic status, maternal smoking during pregnancy, 
sibling order, and (in the IoW cohort) RLRTI were associated with breastfeeding 
duration. These were therefore controlled for in the adjusted models, alongside well-
evidenced confounders from the literature.  
 
Primary Analysis: Non-exclusive breastfeeding 
The effect of non-exclusive breastfeeding on allergic outcomes was examined using 
both adjusted and unadjusted models. These analyses showed no significant effect of 
non-exclusive breastfeeding duration across the ages of 1-or-2, 4, 10, and 18 on 
asthma, eczema, rhinitis or atopy in the IoW cohort (Table 2). 
The validation cohort replicated the non-significant results seen in the IoW cohort for 
eczema, rhinitis, and atopy. However, FAIR children who were breastfed for >0-6 
months were only half as likely to have asthma at age 10 as those not breastfed (Table 
2). This effect was seen in both unadjusted and adjusted (RR=0.50, 95%CI 0.32-0.79, 
p=0.003) models and remains significant after Bonferroni correction (four allergic 
outcomes tested).  
 
Secondary analysis: Exclusive breastfeeding 
Relative to participants never exclusively breastfed, participants exclusively breastfed for 
less than or greater than 4 months did not differ in their risks of long-term asthma or 
allergic disease (Table 3). In unadjusted models, risk of eczema was higher among 
children exclusively breastfed for >4 months relative to non-exclusive breastfeeding in 
the IoW cohort (RR=1.44, 95%CI 1.06-1.95, p=0.018). This did not remain significant 
after adjustment or after Bonferroni correction (four allergic outcomes tested). 
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In the validation cohort, exclusive breastfeeding for >4 months was protective against 
repeated measures of rhinitis relative to non-exclusive breastfeeding, in both unadjusted 
and adjusted (RR=0.36, 95%CI 0.18-0.71, p=0.003) models (Table 3). Additionally, 
exclusive breastfeeding for >0-4 months was protective against asthma at 10 years in 
the adjusted model (RR=0.68, 95%CI 0.46-0.99, p=0.045). This remained significant for 
rhinitis but not asthma after Bonferroni correction (four allergic outcomes tested). 
 
Analysis at each time point for non-exclusive and exclusive breastfeeding 
Analysis of each outcome at each time point was done to determine whether inter- 
cohort differences were due to differences in length of follow-up. Effects of non-exclusive 
and exclusive breastfeeding remained different between the two cohorts even at similar 
follow-up ages (Table S4). 
 
Early wheeze Trajectories 
In the IoW cohort adjusted models, non-exclusive breastfeeding (Table S5) for >6 
months was protective against falling into the late wheeze trajectory, relative to never 
wheezing (RR=0.54, 95%CI 0.32-0.90, p=0.019). Similarly, exclusive breastfeeding 
(Table S6) for >4 months was borderline significantly protective against late wheeze 
(RR=0.57, 95%CI 0.32-1.01, p=0.052).  
 
In the FAIR cohort there were no significant effects of breastfeeding on wheeze 
trajectories in adjusted analyses (Table S5 and S6). However, >6 months non-exclusive 
breastfeeding (Table S5) had the same direction of effect (protective) against late-onset 
wheeze, as observed in the IoW cohort, but did not reach statistical significance. 
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Discussion 
This study found inconsistent protective effects of breastfeeding duration on long-term 
allergic outcomes. Non-exclusive breastfeeding duration had no significant effect on 
long-term allergic disease in the IoW cohort, though in the validation (FAIR) cohort >0-6 
months breastfeeding was protective against asthma until the age of 10. Exclusive 
breastfeeding duration did not affect long-term allergy in the IoW birth cohort, though >4 
months exclusive breastfeeding protected against rhinitis in the validation cohort. Non-
exclusive breastfeeding for >6 months was significantly protective against the late onset 
early wheeze trajectory in the IoW cohort, and had the same direction of effect in the 
validation cohort. This divergence in long-term effects on allergic disease, even between 
two cohorts from the Isle of Wight, shows that current breastfeeding duration guidelines 
are not consistently protective, and highlights the need for further research. 
Primary analysis: Non-exclusive breastfeeding 
Non-exclusive breastfeeding duration did not significantly affect development of allergic 
disease in later childhood and early adulthood in the IoW cohort, suggesting the 
previously observed protective effects against early wheeze (6) do not persist. WHO 
guidance advocates breastfeeding for ≥6 months, and whilst this may provide numerous 
other health benefits, there is no evidence for the IoW cohort that breastfeeding duration 
affects longitudinal risk of asthma or allergic disease. 
 
These results were largely reproduced in the validation cohort, although in FAIR a 
protective effect of non-exclusive breastfeeding for >0-6 months was observed, relative 
to no breastfeeding, against asthma (age 10). This effect is not significant for >6 months 
which does not support a dose response effect, although numbers were small in this 
category. Participation at the follow-up time points was high for both cohorts (Figure 1) 
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so it seems unlikely that the inconsistent results between the two cohorts are due to loss 
to follow up. However the analysis of asthma at age 10 in the FAIR cohort only included 
460 individuals, which is significantly fewer than in the analyses for the other outcomes 
so the possibility of selection bias remains.  
 
Previous comparisons report differences in prevalence of wheeze, rhinitis, and allergic 
sensitisation between the IoW and FAIR cohorts (18), which were established on the 
same island 12 years apart, suggesting the inconsistent effects on asthma may reflect 
general changes in allergic disease prevalence over time. Additionally, breastfeeding 
practices are different between the two cohorts and could contribute to the 
inconsistencies reported here. Whilst the definition of non-exclusive breastfeeding is the 
same for both cohorts, other differences exist. Data on RLRTI and parental atopy were 
unavailable for FAIR, and FAIR participants have not reached 18 years – any protective 
effect of breastfeeding against wheeze (6, 26) may persist to 10 but not 18 years. Our 
data on long-term allergic outcomes span puberty. It could be possible that analysing 
both sexes together has masked different effects of breastfeeding duration on asthma in 
each sex, since puberty is known to have different effects on asthma in males and 
females (27). However, in the IoW cohort, stratifying the 18-year asthma analyses by 
sex revealed no significant effect of breastfeeding duration on asthma in either males or 
females (data not shown). Combining the two cohorts was considered for meta-analysis 
and would increase the statistical power of analyses, however this was not suitable due 
to the differences between the two cohorts. 
 
Our findings agree with several previous studies. While some studies have shown a 
significant protective effect, the majority of these are limited by study design (28), no 
non-breastfed reference category (12, 13, 29, 30), small study size (29, 31), or short 
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follow-up duration (12, 26, 32, 33). A cluster-randomised trial promoting prolonged and 
exclusive breastfeeding found that 6.5-year-old children in the interventional regions had 
increased prevalence of prolonged breastfeeding without a significant reduction in 
allergic symptoms (34), in agreement with our findings. The prospective study design 
used in our study is advantageous as it limits information bias. Additionally, our analysis 
of outcomes using repeated measures allows persistence of outcomes to be taken into 
account. Some studies report protective effects of breastfeeding against allergy at 
younger ages, though we report that protective effects do not persist to adulthood. 
Breastfeeding protects against early childhood wheeze (26, 35), but not all wheezing 
children go on to develop asthma (36). This protective effect on early wheeze has been 
observed in the IoW cohort previously (6). Studies reporting protective effects against 
childhood asthma may therefore observe a protective effect against wheeze, not 
asthma, which is likely to be virus-induced and indicative of the immunological protection 
that breastfeeding confers. Alternatively, breastfeeding could protect against asthma 
through reduction in RLRTI, though removing RLRTI infections from our model did not 
materially alter results (Table S7), and in the IoW cohort the protective effect of longer 
duration breastfeeding against the late-onset wheeze trajectory remained significant 
while adjusting for RLRTI, suggesting that the potential effect of breastfeeding on 
wheeze prevention is not due to protection from RLRTIs.  
 
Additionally the analysis of early wheeze trajectories in the IoW cohort suggests a 
protective effect of longer non-exclusive duration breastfeeding against late wheeze 
(children who do not wheeze at 1-or-2 but go on to wheeze at 4 years of age) but not 
persistent wheeze (children who wheeze at 1-or-2 years and 4 years) relative to never 
wheeze. The same direction of effect is seen in the validation cohort although this does 
not reach statistical significance. This suggests that breastfeeding may be protective 
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against certain subtypes of asthma, in particular the late-onset wheeze trajectory, which 
has been associated with increased allergic sensitization (37) and therefore may 
represent subjects likely to subsequently develop asthma. This analysis could explain 
the inconsistent results seen in this study, and also in the literature. Future research 
should examine breastfeeding relative to early wheeze trajectories. 
 
Categorisation of breastfeeding duration in previous studies varies widely, and any 
categorisation has limitations. Firstly, some studies suggest a non-linear relationship 
between breastfeeding duration and allergic disease (32, 38). Broad categorisation using 
guideline recommendations may therefore mask non-linear relationships. Furthermore, 
women who breastfed briefly may say that they did not breastfeed at all, or conversely 
feel guilty and exaggerate their answer to one week. To address this issue, analyses 
were rerun with a separate ‘1 week’ breastfeeding category: results for all outcomes 
were similar to the primary analysis (data not shown), suggesting that potential bias due 
to misclassification of women between 0-1 weeks is unlikely to affect the results of our 
analysis. 
 
 
Another potential limitation is that we were unable to examine reverse causality: a 
mother’s decision to breastfeed may be influenced by early symptoms of allergy in the 
infant. This could mask any potential effects of breastfeeding on allergy, or result in an 
apparent increase in risk with prolonged breastfeeding. Few studies examine causality, 
though one study found early signs of atopy increases duration of exclusive 
breastfeeding (39). IoW breastfeeding practices recorded at 1 and 2 years after birth 
could be subject to a degree of recall bias, however recall of breastfeeding duration has 
been shown to be quite accurate even 20 years after delivery (40). Non-exclusive 
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breastfeeding does not consider concurrent feeding methods, so a secondary analysis 
was performed examining exclusive breastfeeding. 
 
Secondary Analysis: Exclusive breastfeeding 
Exclusive breastfeeding according to EAACI guidelines provided long-term protection 
against allergy, though this was inconsistent between cohorts. In the IoW cohort, 
exclusive breastfeeding duration had no significant effect on long-term allergy, however 
in the FAIR cohort, exclusive breastfeeding for >4 months was strongly protective 
against rhinitis, and exclusive breastfeeding for >0-4 months was nominally protective 
against asthma. For eczema, and atopy our results agree with current research, which 
suggests that delayed introduction of solids has no benefit; whilst for rhinitis prolonged 
exclusive breastfeeding may be protective. The significant protective effect against 
rhinitis was seen only in the validation cohort and is difficult to interpret, as this cohort’s 
rhinitis definition does not differentiate between atopic and non-atopic symptoms. With 
the publication of the LEAP study(46) and the Consensus statement on peanut 
introduction(47) changes in the timing of introduction of solid foods is recommended, 
particularly the introduction of solid foods and peanuts before 6 months of age. This 
paper is reassuring in the fact that 6 months exclusive breasting does not seem to be 
important for allergy prevention. 
 
Non-exclusive breastfeeding had a stronger protective effect than exclusive 
breastfeeding against asthma at 10 years in the FAIR cohort (RR=0.50 vs. RR=0.68). 
Non-exclusive breastfeeding includes infants who are breastfeeding whilst introducing 
formula feeds, solid food or cow’s milk so perhaps this could explain the inconsistency in 
results between the two cohorts. Solid foods contain many compounds which are foreign 
to infants prior to complementary feeding. Breastfeeding whilst introducing gluten-
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containing foods has been shown to reduce the risk of coeliac disease(41). It is unknown 
whether breastfeeding also protects against immunological intolerance to allergic 
diseases. In the IoW cohort (Table S8), breastfeeding whilst introducing solid foods 
reduced the risk of asthma, compared with solid introduction without concurrent breast 
milk (i.e. ceasing breastfeeding and using alternatives such as formula feeds or cow’s 
milk before introducing solid foods). Additionally concurrent breastfeeding reduced the 
risk of rhinitis in the FAIR cohort. Again, these results are limited by their inconsistency 
between the two cohorts – future studies should explore the potentially protective effect 
of breastfeeding concurrent with food introduction. 
 
Although breastfeeding duration according to guidelines does not consistently protect 
against long-term allergy, breastfeeding may prevent development of allergy through 
interactions that were not assessed here. Firstly, breast milk composition is widely 
variable between mothers (42). Differing concentrations of the main immunoglobulin in 
human breast milk, Immunoglobulin A (IgA), are associated with altered risk of atopy and 
allergy (43). Along with other immunomodulatory factors in breast milk, IgA is thought to 
control binding of antigens to the infant intestinal mucosa, and therefore affects not only 
systemic bacterial invasion but also early microbial colonisation, altering the infant 
microbiome (44). Secondly, the role of the breast milk microbiome may be important 
(45). Thirdly, mode of breastfeeding was not examined in this study: breast milk can be 
given to infants directly from the breast or indirectly using a pump and bottle. The 
sucking mechanism differs, and may affect infant lung development and possibly lung 
function in later life. Few studies examine this mechanism, although a study by Soto-
Ramírez et al. (26) found that direct breastfeeding resulted in a lower risk of wheeze or 
cough in the first 12 months compared with bottled breast milk or formula feeds. Finally, 
very few studies examine the effects of guideline recommendations for breastfeeding on 
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allergy. Since there is conflicting evidence for the effect of breastfeeding duration on 
long-term allergic disease, more research examining these guidelines is required. 
 
Conclusion 
Breastfeeding duration (exclusive or not) had some protective effects against long term 
allergic disease, although these varied even between the two co-located cohorts. 
Breastfeeding duration did not significantly affect risk of allergic disease in the IoW 
cohort, however in the FAIR cohort non-exclusive breastfeeding for >0-6 months was 
protective against asthma at 10 years, and exclusive breastfeeding for >4 months 
protected against repeated rhinitis. Analysis of early wheeze trajectories suggests longer 
duration breastfeeding is protective against late-onset wheeze. WHO guidelines 
advocate breastfeeding for ≥6 months, though our results do not suggest this affords 
protection against long-term asthma, eczema, rhinitis, or atopy. Exclusive breastfeeding 
for ≥4 months is recommended by EAACI guidelines as protective against allergy 
disease, and this study found protective effects of exclusive breastfeeding for >4 months 
against long-term rhinitis in the FAIR cohort. Future studies should examine whether 
aspects of breastfeeding other than duration are important in preventing long-term 
asthma and allergic disease. 
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Tables and Figures 
TABLE 1: Baseline characteristics of participants 
Variable IoW cohort 
(n=1536) 
FAIR alternative 
variable 
FAIR cohort 
(n= 988) 
Non-exclusive 
breastfeeding duration 
   
 No breastfeeding 283 (21.0%)  276 (31.3%) 
 >0 to 6 months 711 (52.9%)  398 (45.2%) 
 >6 months 351 (26.1%)  207 (23.5%) 
Exclusive breastfeeding 
duration 
   
           No breastfeeding 425 (31.2%)  329 (40.5%) 
           >0 to 4 months 744 (54.6%)  437 (53.8%) 
           >4 months 193 (14.2%)  46 (5.7%) 
Maternal socioeconomic 
status 
   
1 (lowest)   209 (15.4%) Did not finish 
school 
12 (1.2%) 
2   240 (17.7%) School 363 (37.7%) 
3   403 (29.7%) Further education 437 (45.3%) 
4   394 (29.0%) Higher education 152 (15.8%) 
5 (highest)   111 (8.2%)   
Maternal smoking during 
pregnancy 
   
 Yes 384 (25.2%)  211 (22.5%) 
 No 1137 (74.8%)  726 (77.5%) 
Season of birth 
   
 Winter 499 (32.5%)  221 (22.8%) 
 Spring 364 (23.7%)  256 (26.4%) 
 Summer 353 (23.0%)  248 (25.6%) 
 Autumn 320 (20.8%)  244 (25.2%) 
Sibling order 
   
 1 510 (42.1%)  401 (41.4%) 
 2 419 (34.6%)  316 (32.6%) 
 ≥3 283 (23.3%)  252 (26.0%) 
Sex 
   
 Male 786 (51.2%)  495 (51.7%) 
 Female 750 (48.8%)  462 (48.3%) 
Parental asthma 
   
 None 1208 (80.4%)  615 (65.1%) 
 Maternal 147 (9.8%)  168 (17.8%) 
 Paternal 132 (8.8%)  117 (12.4%) 
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 Both 16 (1.1%)  45 (4.8%) 
Parental eczema 
   
 None 1242 (82.7%)  629 (67.1%) 
 Maternal 164 (10.9%)  193 (20.6%) 
 Paternal 81 (5.4%)  69 (7.4%) 
 Both 15 (1%)  47 (5%) 
Parental rhinitis 
   
 None 1030 (68.4%)  473 (51.5%) 
 Maternal 255 (16.9%)  194 (21.1%) 
 Paternal 176 (11.7%)  164 (17.9%) 
 Both 44 (2.9%)  87 (9.5%) 
Parental atopy 
 n/a  
 None 744 (49.4%)  - 
 Maternal 377 (25.0%)  - 
 Paternal 244 (16.2%)  - 
 Both 142 (9.4%)  - 
RLRTI 211 (15.4%) n/a - 
 
  
OUTCOMES 
  
Asthma at 10 201 (14.7%) Asthma at 10 101 (19.7%) 
Asthma at 18 231 (17.7%)  
Eczema at 1 or 2 196 (14.2%) Eczema at 1 168 (18.7%) 
Eczema at 4 145 (11.9%) Eczema at 2 204 (23.9%) 
Eczema at 10 186 (13.7%) Eczema at 3 163 (18.4%) 
Eczema at 18 161 (12.3%) Eczema at 10 258 (31.2%) 
Rhinitis at 1 or 2 217 (15.8%) Rhinitis at 1 184 (20.4%) 
Rhinitis at 4 65 (5.4%) Rhinitis at 2 141 (16.4%) 
Rhinitis at 10 308 (22.6%) Rhinitis at 3 133 (14.9%) 
Rhinitis at 18 468 (35.8%) Rhinitis at 10 198 (23.9%) 
Atopy at 1 or 2 41 (7.8%) Atopy at 1 20 (2.6%) 
Atopy at 4 192 (19.6%) Atopy at 2 54 (8.2%) 
Atopy at 10 279 (26.9%) Atopy at 3 76 (11.8%) 
Atopy at 18 353 (41.4%) Atopy at 10 145 (24.6%) 
Numbers of subjects in each subgroup are shown (with % of total); The full IoW cohort 
has n = 1,536 subjects recruited at birth and n = 1,456 available for follow-up; the full 
FAIR cohort has n = 988 subjects recruited at birth; where numbers total to less than this 
the difference is due to missing data. Column 3 displays variables for the FAIR cohort if 
different from the IoW cohort.
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TABLE 2: Effect of duration of non-exclusive breastfeeding on risk of allergic disease in 
the IoW and FAIR cohorts 
 Duration of non-exclusive breastfeeding (months) 
(RR; 95 CI; p value) 
 0 >0-6 >6 
IoW Unadjusted    
Asthma Ref. 1.06; (0.80-1.40); 0.709 0.91; (0.65-1.27); 0.563 
Eczema Ref. 1.30; (0.98-1.71); 0.065 1.20; (0.88-1.63); 0.253 
Rhinitis Ref. 0.99; (0.85-1.15); 0.848 0.92; (0.77-1.09); 0.327 
Atopy Ref. 1.03; (0.84-1.26); 1.029 1.05; (0.84-1.31); 0.695 
IoW Adjusted  
Asthma Ref. 1.02; (0.75-1.39); 0.908 0.95; (0.66-1.36); 0.769 
Eczema Ref. 1.32; (0.97-1.80); 0.076 1.10; (0.77-1.57); 0.585 
Rhinitis Ref. 1.01; (0.85-1.20); 0.945 0.90; (0.74-1.10); 0.311 
Atopy Ref. 0.98; (0.80-1.21); 0.869 1.04; (0.83-1.30); 0.733 
FAIR 
Unadjusted 
   
Asthma Ref. 0.57; (0.37 - 0.87); 0.010 0.82; (0.52 - 1.29); 0.381 
Eczema Ref. 1.05; (0.85-1.30); 0.650 1.09; (0.85-1.40); 0.478 
Rhinitis Ref. 0.93; (0.78-1.11); 0.408 0.86; (0.69-1.07); 0.172 
Atopy Ref. 1.09; (0.78-1.54); 0.605 1.40; (0.97-2.03); 0.069 
FAIR Adjusted 
 
  
Asthma Ref. 0.50; (0.32 - 0.79); 0.003 0.89; (0.56 - 1.41); 0.614 
Eczema Ref. 1.01; (0.81-1.26); 0.940 1.05; (0.81-1.36); 0.697 
Rhinitis Ref. 1.01; (0.84-1.22); 0.925 0.95; (0.75-1.20); 0.675 
Atopy Ref. 0.97; (0.69-1.35); 0.848 1.14; (0.78-1.67); 0.490 
Effect of breastfeeding duration was assessed on asthma (n=1087) at ages 10 and 18, 
and on eczema (n=1106), rhinitis (n=1109), and atopy (n=1052) at ages 1-or-2, 4, 10 
and 18 in the IoW cohort; and on asthma (n=460) at 10 years, and on eczema (n=834), 
rhinitis(n=819), and atopy (n=791) at 1, 2, 3 and 10 years in the FAIR cohort. CI: 
confidence interval. IoW adjusted models controlled for maternal socioeconomic status, 
maternal smoking during pregnancy, season of birth, sibling order, sex, parental history 
of relevant allergic disease, and for asthma also RLRTI. Significant effects are shown in 
bold font. FAIR cohort adjusted models controlled for maternal education, maternal 
smoking during pregnancy, season of birth, sibling order, sex, and parental history of 
relevant allergic disease. Significant effects are shown in bold font. 
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TABLE 3: Effect of exclusive breastfeeding duration on risk of allergic disease in the 
IoW and FAIR cohorts 
 Duration of exclusive breastfeeding (months) 
(RR; 95 CI; p value) 
 0 >0-4 >4 
IoW Unadjusted 
   
Asthma Ref. 1.02; (0.78-1.34); 0.873 0.91; (0.62-1.35); 0.648 
Eczema Ref. 1.01; (0.79-1.31); 0.923 1.44; (1.06-1.95); 0.018 
Rhinitis Ref. 0.99; (0.85-1.15); 0.892 0.98; (0.81-1.20); 0.867 
Atopy Ref. 1.02; (0.84-1.24); 0.863 1.19; (0.94-1.50); 0.157 
IoW Adjusted   
Asthma Ref. 1.04; (0.76-1.41); 0.812 1.00; (0.66-1.50); 0.982 
Eczema Ref. 1.11; (0.83-1.48); 0.495 1.37; (0.97-1.93); 0.075 
Rhinitis Ref. 1.04; (0.88-1.23); 0.670 1.00; (0.81-1.24); 0.978 
Atopy Ref. 0.94; (0.77-1.15); 0.533 1.09; (0.86-1.37); 0.487 
FAIR Unadjusted   
Asthma Ref. 0.74; (0.51 - 1.08); 0.117 0.21; (0.03 - 1.41); 0.107 
Eczema Ref. 1.05; (0.87-1.28); 0.592 1.10; (0.72-1.66): 0.665 
Rhinitis Ref. 0.96; (0.82-1.14); 0.660 0.31; (0.15-0.62); <0.001 
Atopy Ref. 1.19; (0.87-1.62); 0.285 1.11; (0.61-2.04); 0.732 
FAIR Adjusted 
 
  
Asthma Ref. 0.68; (0.46 - 0.99); 0.045 0.20; (0.03 - 1.37); 0.101 
Eczema Ref. 1.03; (0.84-1.27); 0.746 1.07; (0.70-1.63); 0.762 
Rhinitis Ref. 1.05; (0.88-1.24); 0.614 0.36; (0.18-0.71); 0.003 
Atopy Ref. 1.09; (0.80-1.49); 0.574 0.96; (0.52-1.77); 0.884 
Effect of exclusive breastfeeding duration was analysed on asthma(n=1011) at 10 and 
18, and on eczema(n=1031), rhinitis (n=1034), and atopy (n=978) at 1-or-2, 4, 10 and 18 
in the IoW cohort; and on asthma at 10, and eczema, rhinitis, and atopy at 1, 2, 3, and 
10 years in the FAIR cohort. CI: confidence interval. IoW cohort adjusted models 
controlled maternal socioeconomic status, maternal smoking during pregnancy, season 
of birth, sibling order, sex, parental history of relevant allergic disease, and for asthma 
also RLRTI. FAIR cohort adjusted models controlled for maternal education, maternal 
smoking during pregnancy, season of birth, sibling order, sex, and parental history of 
relevant allergic disease. Significant effects are shown in bold font. 
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Figure 1: IoW and FAIR Cohort participation rates and follow up 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Flow diagram demonstrating the IoW and FAIR cohort participation rates at each time-
point from birth up to 18 and 10 years respectively. Percentages are calculated out of the 
number of children born on the IoW during the recruitment period. 
IoW Cohort FAIR Cohort
